A clinical trial to assess a potential new treatment for traumatic brain injury (TBI) is set to enter its next phase of testing in the US.
Neurorehabilitation technology company Kinetic Muscles Inc (KMI) announced it has received a two-year Phase II Small Business Innovation Research grant to study a new treatment for army veterans returning from active duty with traumatic brain injury.
KMI will collaborate with the Division of Neuropsychology at Emory University, the Department of Defense, the US Department of Veterans Affairs and the University of Advancing Technology.
The firm's therapy combines neuropsychological therapy with the latest in digital gaming technology, which is said to be able to improve cognitive ability, dexterity, memory, thought processing and reasoning.
"Patients with stroke and TBI experience similar cognitive and movement deficits. KMI technology addresses rehabilitation for both groups through repetitive training of specific tasks," said Ed Koeneman, chief operating officer at KMI and principal investigator for the study.
KMI was founded in 2001 and is based in the city of Tempe, Arizona.
Serious Law, award winning traumatic brain injury law firm
